The Serum Institute of India (SII) on Friday announced that the world’s biggest vaccine manufacturer has commenced the production of the first batch of the new Covid-19 vaccine ‘Covovax’, developed by Novavax, at their facility in Pune.
“A new milestone has been reached. This week we began our first batch of Covovax (a COVID-19 vaccine developed by Novavax) at our facility, here in Pune,” Serum Institute said in an official statement.
SII CEO Adar Poonawalla took to Twitter regarding the development and said that “the vaccine has great potential to protect our future generations below the age of 18”.
“Excited to witness the first batch of Covovax (developed by Novavax) being manufactured this week at our facility in Pune. The vaccine has great potential to protect our future generations below the age of 18. Trials are ongoing. Well done team,” he said.